首页 › 基金 › BRAIDWELL LP › SYRE

BRAIDWELL LP 对 SYRE 的持仓历史

SPYRE THERAPEUTICS INC · 医疗保健

BRAIDWELL LP 在 Q2 2026 的 13F 申报中披露持有 SYRE(SPYRE THERAPEUTICS INC)879,467 股,市值约 US$78.1M,约占其申报组合的 3.07%,在其申报持仓中市值排名第 5 位。 BRAIDWELL LP 最近 11 个申报季度中有 11 个季度披露了 SYRE 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q2 2026)879.47K 股
申报持仓市值$78.08M
组合权重3.07%
首次申报Q4 2023
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

BRAIDWELL LP 对 SYRE 的持仓演变

BRAIDWELL LP 于 Q4 2023 首次披露 SYRE 持仓:515,000 股(约 US$11.1M)。 该持仓在 Q2 2026 达到峰值 879,467 股,市值约 US$78.1M。 在 11 次申报中,BRAIDWELL LP 2 次增持、4 次减持、4 次保持不变。 最近一期申报(Q2 2026)显示持股 879,467 股、市值约 US$78.1M,环比减持 -53,356 股。。 持仓曾出现大幅变动:Q2 2024 增持约 388% (随后一个季度股价基本持平)、Q4 2025 减持约 37% (随后一个季度股价上涨 54%)、Q1 2026 减持约 43% (随后一个季度股价上涨 76%)。

逐季持仓明细

季度股数金额变化
Q4 2023 515.00K $11.08M 新进
Q1 2024 515.00K $19.53M 持有
Q2 2024 2.51M $59.12M 增持
Q3 2024 2.19M $64.40M 减持
Q4 2024 2.58M $60.03M 增持
Q1 2025 2.58M $41.60M 持有
Q2 2025 2.58M $38.60M 持有
Q3 2025 2.58M $43.21M 持有
Q4 2025 1.63M $53.55M 减持
Q1 2026 932.82K $47.05M 减持
Q2 2026 879.47K $78.08M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SYRE 与 13F 数据

SYRE(SPYRE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 70 只申报持有 SYRE,申报仓位最大的包括:PERCEPTIVE ADVISORS LLC (US$383.5M), RTW INVESTMENTS, LP (US$377.5M), Paradigm Biocapital Advisors LP (US$341.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SYRE 的基金

查看 SYRE 的全部基金持有人 →

常见问题

How long has BRAIDWELL LP held SYRE?

BRAIDWELL LP has disclosed SYRE holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is BRAIDWELL LP's current position in SYRE?

As of Q2 2026, BRAIDWELL LP holds 879.47K shares of SYRE (SPYRE THERAPEUTICS INC), valued at $78.08M, representing 3.07% of its reported portfolio and ranking #5.

Has BRAIDWELL LP been buying or selling SYRE?

In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in SYRE. The position peaked in Q2 2026 at 879.47K shares.

Which other funds hold SYRE?

Other major institutional holders of SYRE include PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.